Pushpendra D Pratap | Cervical Cancer | Best Researcher Award

Posted on by ScienceFather

Ā Dr. Pushpendra D Pratap |Cervical Cancer| Best Researcher Award

 

Completed my Ph.D. in Biochemistry under the supervision of Prof. Syed Tasleem Raza, Professor, Department of Biochemistry, and Controller of Examination (COE), from ERA University. I have a profound ability to comprehend complex technologies in biochemistry, genomics, proteomics, and more.

Profile

  1. Orcid

 

  1. Scholar

šŸ”¬ Current Research

I am currently working on:

  • Single nucleotide gene polymorphisms (SNPs) of interleukins (ILs) and their association with cervical cancer susceptibility.
  • Evaluation of interleukins and other markers’ levels through ELISA.
  • Human papillomavirus (HPV) analysis through RT-PCR, a recognized causative agent for cervical cancer and other carcinomas.
  • Diagnostic tests for HLA-B-27 and MDTB through RT-PCR.
  • COVID-19 testing through RT-PCR.

Additionally, I have experience in the molecular biology of various cancers and other diseases, focusing on signaling pathways, angiogenesis, cell proliferation, apoptosis, autophagy, inflammation, oxidative stress, and targeted therapeutic interventions.

šŸ§Ŗ Expertise

  • Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS)
  • Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
  • Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
  • KingFisher Duo Prime Extraction System & QS 5Dx qPCR Machine and Analysis Software

šŸŽ“ Professional Qualification

  • Ph.D. in Biochemistry (2024) from ERA University (EU), Lucknow.
  • Certificate in Emergency Medical Technician (EMT) Basic with ā€˜Bā€™ grade from PMKVY in 2017.
  • Master of Science in Biochemistry (2014) from CSJM University Kanpur.
  • Bachelor of Science (Zoology, Botany, Chemistry) (2011) from University of Lucknow, Lucknow.

šŸ“š Scholastic Qualification

  • Higher Secondary (XII) with U.P. Board in 2007.
  • High School (X) with U.P. Board in 2005.

šŸ· Positions

  • Research Assistant: Jan 2015 to July 2015, Department of Pathology, ERAā€™s Lucknow Medical College & Hospital, Lucknow.
  • DBT Junior Research Fellow: July 2015 to March 2019, Department of Obstetrics & Gynecology, ERAā€™s Lucknow Medical College & Hospital, Lucknow.
  • Research Analyst: March 2019 to present, Research Metabolic Unit, ERAā€™s Lucknow Medical College & Hospital, Lucknow.

šŸ§‘ā€šŸ”¬ Project/ Research Work Experience

Major Projects

  • Inflammatory Pathway Gene Polymorphisms and Cervical Cancer Progression
    • Title: Co-relative significance of inflammatory pathway gene polymorphisms – Interleukin -1-RN, 1Ī² (-511C/T and +3953C/T) , 6 (174A/G) and 10 (-1082 A/G and -819C/T), with interleukin serum levels and intensity of angiogenesis in the progression of HPV positive cervical cancer
    • Duration: July 2015 to March 2019
    • Location: Department of Obstetrics & Gynecology, ERAā€™s Lucknow Medical College & Hospital, Lucknow.
  • CYP 46A1 Gene Polymorphism in Cataract
    • Duration: September to December 2013
    • Location: Department of Biotechnology, Central Research Laboratory, ERAā€™s Lucknow Medical College & Hospital, Lucknow.

šŸ“š Teaching Experience

  • One year teaching experience in Biology with R.P.S. Inter College.
  • Two years of home tuition in Biology.

 

šŸ”¬ Biological Cognizance

Biochemistry:

  • Qualitative and Quantitative Analysis of Biomolecules
  • Paper Chromatography, Thin Layer Chromatography, Electrophoretic Techniques

Molecular Biology:

  • DNA and RNA Isolation, Enzyme Kinetics, PCR, RT-PCR, RFLP

Microbiology:

  • Sterilization Techniques, Antibiotic Sensitivity Tests, Microbial Staining, Environmental Monitoring

Immunological Techniques:

  • ELISA, Radioimmunoassay (RIA), Blood Group Identification, Serological Tests

šŸ† Awards/ Honors

  • International Best Poster Presentation Award at the 11th International Science Congress (2023) at Pacific University, Udaipur, Rajasthan, India.

Publications Top Notes šŸ“

  • The application of UDL and SoTL to health care education
    • Year: 2024
    • Authors: Ciolfi, M.; Howard, L.
    • Source: New Directions for Teaching and Learning

 

  • Perceptions of Ontario chiropractors on business education in chiropractic schools
    • Year: 2021
    • Authors: Ciolfi, M.A.; Azad, A.; Al-Azdee, M.; Nguyen, A.; Panah, B.A.
    • Source: Journal of Chiropractic Education

 

  • Gender diversity in chiropractic leadership: a cross-sectional study
    • Year: 2021
    • Authors: Azad, A.; Maiers, M.; Stuber, K.; Ciolfi, M.
    • Source: Journal of the Canadian Chiropractic Association

 

  • Response of Chiropractic Organizations to the COVID-19 Pandemic: A Descriptive Report
    • Year: 2020
    • Authors: Johnson, C.D.; Little, C.S.; Sterling, T.A.; Boghosian, K.; Ciolfi, M.A.
    • Source: Journal of Manipulative and Physiological Therapeutics

 

  • The relationship between chiropractor required and current level of business knowledge
    • Year: 2017
    • Authors: Ciolfi, M.A.; Kasen, P.A.
    • Source: Chiropractic and Manual Therapies

 

Teng Zhang | Gynecologic Oncology | Young Scientist Award

Posted on by ScienceFather

Ms. ā€ŒTeng Zhang |Gynecologic Oncology |Young Scientist AwardĀ 

Ms at Qilu Hospital of Shandong University, China

Ms. Teng Zhang is an accomplished Attending Doctor in the Department of Obstetrics and Gynecology at Qilu Hospital of Shandong University. With a Ph.D. and Master’s degree from Cheeloo College of Medicine, Shandong University, and a Bachelor’s degree from Jining Medical College, Ms. Zhang has extensive experience in clinical practice and research. Notable achievements include publications on cervical cancer in high-impact journals and awards in English teaching competitions. Dr. Zhang’s research focuses on fertility-sparing treatments, m6A methylation, and immune cell variations in cervical cancer, underscoring a strong commitment to advancing women’s health.

Profile

 

šŸŽ“ Education Background

Sept. 2015 – Sep. 2018: Ph.D., Cheeloo College of Medicine, Shandong University. Sept. 2013 – Sep. 2015: Master, Cheeloo College of Medicine, Shandong University. Sept. 2008 – Jun. 2013: Bachelor of Medicine, Jining Medical College. Sept. 2005 – Jun. 2008: Qingdao No.2 Middle School

šŸ’¼ Research/Work Experience

July 2022 – Present: Attending Doctor, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University. Nov. 2018 – June 2021: Resident, Department of Gynecology and Obstetrics, Qilu Hospital of Shandong University. June 2016 – June 2017: Visiting Scholar, Griffith University, Australia

šŸ† Scholarships and Awards

2023: Young Teachers English Teaching Competition, Second Prize, Cheeloo College of Medicine, Shandong University, 2021: The First “Guangzhi Cup” English Teaching Competition in Qilu Hospital of Shandong University, Third Prize, July 2013: Excellent Graduate of Shandong Province, Oct. 2009: National Scholarship

Publications Top Notes šŸ“

  • Xuji Jiang, Chuanli Feng, Wanying Sun, Teng Zhang*, Baoxia Cui. “The top 100 most cited articles on fertility-sparing treatments for cervical cancer: A bibliometric analysis.” Heliyon, 10(11), 2024.

 

  • Zhonghao Mao, Bingyu Wang, Teng Zhang, Baoxia Cui*. “The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications.” Cell Death and Disease, 2023, 14(734).

 

  • Teng Zhang, Jun Jiao, Xinlin Jiao, Lu Zhao, Xinli Tian, Qing Zhang, Daoxin Ma, Baoxia Cui*. “Aberrant frequency of TNFR2+ Treg and related cytokines in patients with CIN and cervical cancer.” Oncotarget, 2017, 9(4).

 

  • Bingyu Wang, Zhonghao Mao, Jinwen Ye, Xinlin Jiao, Teng Zhang, Qi Wang, Sai Han, Youzhong Zhang, Chunling Wang, Taotao Dong, Baoxia Cui. “Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.” The Journal of Immunology, 2024, 15(212).

 

  • Zhang W, Tian X, Mumtahana F, Jiao J, Zhang T, Croce K.D., Cui B*. “The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer.” BMC Cancer, 2015, 15,717.

 

  • Jun Jiao, Teng Zhang, Xinlin Jiao, Tingting Huang, Lu Zhao, Daoxin Ma, Baoxia Cui*. “hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion.” J Cell Physiol, 2019, 1-9.

 

  • Xinlin Jiao, Siying Zhang, Jun Jiao, Teng Zhang, Wenjie Qu, Guy Mutangala Muloye, Beihua Kong, Qing Zhang, Baoxia Cui*. “Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.” Clin Epigenetics, 2019, 11(120).